News

CMO location drives site selection for Parkinsonian imaging trial, requiring geographic proximity to manufacturing over patient populations.

Johnson & Johnson sells Laminar program to newly formed Jaguar LAA for left atrial appendage closure technology development and...

Iza-bren 2.5 mg/kg dose advances to Phase 3 in EGFR-mutated NSCLC after demonstrating superior efficacy and manageable safety in...

Tam-Peli meets primary endpoint for relapsed small-cell lung cancer in phase III trial, showing OS benefit over topotecan in...

Ennov appoints Dr. Oxana Pickeral as Chief Executive Officer, succeeding 27-year founder Olivier Pâris amid accelerating regulatory compliance demand.

PerZeption receives NEI SBIR grant to develop a photostress recovery test for AMD on tablet hardware, aiming to detect...

Lyell completes LYL273 manufacturing transfer to its Bothell facility, though the Phase 1/2 colorectal cancer trial now faces enrollment...

China's drug regulator accepts NCX 470 NDA for review, advancing Nicox's nitric oxide-donating glaucoma drop toward potential approval in...

Headlands Research opens Grand Rapids site led by rheumatology investigator Eric Slavin, expanding clinical trial capacity in the Midwest.

Velocity Clinical and Stitch expand partnership across 70+ sites, achieving a 9-point reduction in no-show rates and boosting screening...